Clinical Research

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

TRILUMINATE update: TEER with Abbott’s TriClip device still safe, effective after 3 years

Treatment with TriClip has been consistently associated with minimal adverse events and significant improvements in quality of life. This latest update represents data from nearly 100 patients three years after implantation.  

Thumbnail

Polaris Dawn astronauts will undergo brain MRIs upon landing

The scans will be conducted earlier than any other post-flight imaging of astronauts on record. 

CT scans highlight impact of semaglutide on body composition

Body composition metrics derived from CT scans provide greater insight into how losing weight affects the body from a cardiometabolic perspective.

Breast arterial calcifications (BACs) identified on screening mammograms may help identify women who face a heightened risk of developing cardiovascular disease (CVD), according to a new analysis published in Clinical Imaging.

Nearly 25% of women with breast arterial calcifications on mammo develop heart disease

Specifically, women with BACs on their mammogram may be at an increased risk of atherosclerotic cardiovascular disease.

Harlan Krumholz, MD, SM, editor-in-chief of the Journal of the American College of Cardiology (JACC), and a cardiologist and the Harold H. Hines, Jr. Professor of Medicine at the Yale school Medicine, explains changes in how JACC reviews articles and disseminates information.

A new vision for the JACC: Interview with JACC Editor-in-Chief Harlan Krumholz

Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology (JACC), explains changes in how the journals will be reviewing articles and disseminating information.
 

Thumbnail

‘An excellent outcome’: TAVR safe and effective for patients in their nineties

Bleeding and vascular complications were more common, but one-year outcomes confirmed patients in their nineties should still be considered for TAVR.

Thumbnail

Baseline TR linked to lower quality of life after TAVR, M-TEER—are more interventions the answer?

Patients presenting for TAVR or M-TEER with baseline moderate or severe tricuspid regurgitation were associated with lower post-treatment KCCQ scores and a higher mortality rate. Perhaps treating more of these patients with tricuspid valve repair or replacement could make a difference, researchers noted. 

MRI image of a fetus inside the mother on an MRI scan to assess brain development. Image courtesy of RSNA.

Fetal MRI safe on 3T scanners, new analysis shows

MRI exams are crucial for investigating fetal abnormalities, but past concerns have been expressed about whether the modality could affect intrauterine growth.